Glycoproteomic Innovator Grant: Run up to 200 samples for biomarker discovery with GlycoVision. Apply now until Aug 16, 2024!


InterVenn Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–InterVenn Biosciences, a life science company pioneering glycoproteomics to improve human health, today announced that senior management will present at the J.P. Morgan 41st annual Healthcare Conference on January 11, 2023 at 8:30 a.m. Pacific.

InterVenn’s management team will be available for one-on-one meetings with investors, analysts and other interested parties during the conference.


InterVenn Contact
Ramuné Carothers
Vice President, Corporate Communications
InterVenn Biosciences

Investor Contact
David Deuchler, CFA
Gilmartin Group

Get in touch